PRINCETON, N.J. & NEW YORK--(BUSINESS WIRE)--PharmaNet Development Group, Inc. (NASDAQ: PDGI) and Analytica International, Inc., a wholly-owned subsidiary of Accentia Biopharmaceuticals, Inc. (NASDAQ: ABPI), today announced that they have entered into a strategic alliance that will allow the companies to provide a broader range of clinical development and commercialization expertise to their respective clients.
